Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Oragenics Inc (OGEN)

Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Oragenics Q3 2025 Shareholder Update Business Wire - Wed Nov 12, 7:30AM CST

Building on Solid Ground: From Vision to Execution Restoring Compliance, Advancing Innovation, Preparing for Clinical Milestones

OGEN : 0.8437 (-7.69%)
Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency Business Wire - Tue Oct 21, 7:00AM CDT

Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, announced today that it has regained...

OGEN : 0.8437 (-7.69%)
Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development Business Wire - Tue Oct 7, 7:30AM CDT

Clinical-Stage Biotechnology Company Leverages Artificial Intelligence

OGEN : 0.8437 (-7.69%)
Oragenics Q2 2025 Shareholder Update GlobeNewswire - Mon Aug 11, 7:45AM CDT

Advancing Brain-First Recovery Platform Toward Clinical Milestones Pioneering Intranasal Therapeutics for Concussion SARASOTA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American:...

OGEN : 0.8437 (-7.69%)
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial GlobeNewswire - Thu Jul 31, 7:30AM CDT

SARASOTA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal drug delivery for neurological conditions, today...

OGEN : 0.8437 (-7.69%)
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development GlobeNewswire - Wed Jul 16, 7:39AM CDT

SARASOTA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has...

OGEN : 0.8437 (-7.69%)
Oragenics Completes Approximately $16.5 Million Offering GlobeNewswire - Wed Jul 2, 3:15PM CDT

OGEN : 0.8437 (-7.69%)
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants GlobeNewswire - Tue Jul 1, 7:31AM CDT

OGEN : 0.8437 (-7.69%)
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium GlobeNewswire - Tue Jun 10, 7:30AM CDT

OGEN : 0.8437 (-7.69%)
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split GlobeNewswire - Wed May 28, 6:00AM CDT

OGEN : 0.8437 (-7.69%)

Barchart Exclusives

Did the QQQ Bull Run Just End? Here’s Why This Candlestick is a Bearish Confirmation. Barchart - 3 minutes ago
Our senior chart strategist explains why a major change just happened in the market, and what investors need to know about it now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot